Monday, March 30, 2020

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.

from Moneycontrol Business News https://ift.tt/3artekw

No comments:

Post a Comment

A 'non-event Budget' for stock market: Is that good news for Nifty which fell 1,000 points in January?

As Budget 2026 approaches, analysts expect a low-impact event for equities amid muted expectations. With Nifty already down sharply in Janua...